Subscribe To
Emergent biosolutions to cut 5% of its workforce in reorganization effort
Emergent BioSolutions Inc. EBS, +9.80% is cutting 132 jobs, or approximately 5% of its workforce in a reorganization that the company says will sharpe...
January 9, 2023, 8:17 am
Is first trust nyse arca biotechnology etf (fbt) a strong etf right now?
Smart Beta ETF report for FBT...
January 9, 2023, 7:32 am
Molecular partners provides updates at 41st annual jpm healthcare conference
ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., Jan. 08, 2023 (GLOBE NEWSWIRE) — Ad hoc announcement pursuant to Art. 53 LR : Molecular Partners A...
January 8, 2023, 8:00 pm
Scrutinizing psychedelic stocks
What makes a psychedelic company compelling? Analyst Alex Carchidi has a background in biotech and focu...
January 8, 2023, 11:30 am
Bmez: biotech fund generated high yield last year, but seems unsustainable
BMEZ's portfolio has a combination of unknown small-cap "next generation" healthcare holdings and some familiar names in the field of biotechnology. L...
January 8, 2023, 6:38 am
Vir biotechnology: the first entry in my long term value portfolio
Today, I explain why I've taken a position in VIR, including going over its pipeline, partners, and anticipated milestones. I then look at the company...
January 8, 2023, 3:25 am
2 stocks that could double your money in 2023
These biotechs could crush the market, but there is more to the story....
January 7, 2023, 10:07 am
Xoma announces new employment inducement grants under nasdaq listing rule 5635(c)(4)
EMERYVILLE, Calif., Jan. 06, 2023 (GLOBE NEWSWIRE) — XOMA Corporation (Nasdaq: XOMA) (“XOMA” or the “Company”), the ...
January 7, 2023, 12:00 am
3 biotech companies to watch in 2023
biotech stocks are in high demand right now, with good reason. Indeed, these ...
January 6, 2023, 6:50 pm
Jefferies' michael yee on biogen as fda could be on the verge of approving alzheimer's drug
Michael Yee, Jefferies managing director, joins 'The Exchange' to discuss biotech and the FDA's looming...
January 6, 2023, 2:09 pm
Lecanemab alert: what would alzheimer's drug approval mean for biogen (biib) stock?
One stock that's trading in the right direction today is prominent mega-cap biotech stock Biogen (NAS...
January 6, 2023, 2:07 pm
Abbvie briefly breaks out after tapping immunome in $30 million cancer deal
AbbVie stock briefly broke out Friday after the company signed a $30 million deal with small biotech Im...
January 6, 2023, 1:45 pm
Celularity’s placental-derived allogeneic cell therapy provides clinically meaningful benefit and durable biological effect in patients with moderate to severe crohn’s disease in phase 1, phase 1b/2a
Legacy studies employing a single treatment course of two infusions seven days apart demonstrated greatest benefit in three early studies Data support...
January 6, 2023, 1:10 pm
Chinook therapeutics: best biotech for kidney disease exposure, with catalysts
2023 should be a year of progress on kidney disease, with multiple catalysts lined up from multiple companies. Chinook Therapeutics, Inc. has the best...
January 6, 2023, 12:21 pm
Why is fate therapeutics (fate) stock down 62% today?
Fate Therapeutics (NASDAQ: FATE ) stock is falling hard on Friday after the company announced the termination of its collaboration with Janssen Biotec...
January 6, 2023, 10:56 am
Fate therapeutics stocks heads for record selloff after janssen collaboration terminated and job cuts
Shares of Fate Therapeutics Inc. FATE, -1.08% plunged 56.8% in premarket trading, putting them on track for a record one-day selloff, after the biopha...
January 6, 2023, 8:49 am
2 under-the-radar biotech stocks to buy in 2023
These biotechnology stocks are pushing ahead with promising innovations....
January 6, 2023, 8:45 am
Crispr, genetics and ai — why 2023 could be the year for biotech stocks
If there's one biotech area to watch in 2023, it's genetic medicine, like CRISPR. But other trends also...
January 6, 2023, 8:00 am
Fate alert: monsey law firm of wohl & fruchter llp investigating potential securities claims against fate therapeutics, inc.
MONSEY, N.Y., Jan. 05, 2023 (GLOBE NEWSWIRE) — The law firm of Wohl & Fruchter LLP is investigating whether Fate Therapeutics, Inc. (Nasdaq: FATE) (...
January 6, 2023, 1:00 am
Cytomx shares surge more than 50% on moderna partnership
CytomX Therapeutics Inc. CTMX, +7.19% shares soared more than 50% in the extended session Thursday after the small ...
January 5, 2023, 5:11 pm